Pandemic Perspectives: Remdesivir, Favipiravir’s Eventful Journeys In India A Year On

 
• By Anju Ghangurde

COVID-19 doesn't seem to be going away any time soon and antivirals remdesivir and favipiravir remain part of the treatment armamentarium. “Safety inventories” are in place for remdesivir in India, while a key physician anticipates an uptick in the use of favipiravir amid a surge in cases in some parts of the country.

stairway in the woods
Tracing the journey of key antivirals in India amid COVID-19 • Source: Shutterstock

More from India

More from Focus On Asia